Can-Fite Reports Third Quarter 2022 Financial Results & Provides Clinical Update
PETACH TIKVA, Israel, November 25, 2022--(BUSINESS WIRE)--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and…